Status
Conditions
Treatments
About
Reducing the dependency on medication in lowering fever, which is one of the most common symptoms in childhood, and developing safer and more feasible alternative methods are important for child health. This study is planned to evaluate the effect of warm water foot baths on vital signs and pain in children and to scientifically examine this effect with a randomized controlled trial.
Full description
Fever is one of the most common symptoms in childhood, especially in children under the age of five. While it is the most frequent reason for visits to health institutions, it constitutes 25% of pediatric emergency visits. Lack of knowledge about fever in parents triggers fear, and the thought that it can cause seizures, disability, and brain damage induces anxiety and panic in many families. In the presence of anxiety and panic, families may quickly resort to early and incorrect treatment. Administering less medication than necessary for low fever or high doses for high fever, repeated use of antipyretics, and inappropriate use of antibiotics lead to ineffective management, causing an increase in repeated emergency visits and unnecessary crowding in emergency services. Published guidelines on high fever have emphasized focusing on pain and comfort rather than reducing fever in children. It is reported that foot baths, preferred in pain management, effectively reduce pain and increase comfort. Additionally, guidelines related to fever highlight that warm applications after medication administration can effectively lower persistent fever. Warm water foot bath therapy dilates blood vessels, increases blood circulation, releases heat as sweat, and supports increased oxygenation. Increased circulation improves tissue nutrition and reduces stress. In a study by Ishita et al. (2017), it was observed that body temperature decreased in children who had a warm water foot bath. Similarly, studies by Sunar (2017) and Retnam and Sophia (2018) reported that warm water foot baths were effective in reducing fever in individuals with complaints of high fever.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
The child is a patient with "Yeşil alan" (specific condition or disease). The child has no chronic illness. The child has not used any other antipyretic medication in the last 6 hours. The child has been administered 15 mg/kg of oral paracetamol as prescribed by the doctor.
The child and their parent(s) have volunteered to participate in the study. Written consent from the parent(s) is obtained.
Exclusion criteria
Individuals who have not agreed to participate voluntarily in the study. Children who have been unable to take paracetamol due to spillage or vomiting. Children with compromised skin integrity. Individuals who have undergone surgical procedures that would hinder the child's activity.
Primary purpose
Allocation
Interventional model
Masking
60 participants in 2 patient groups
Loading...
Central trial contact
sermin dinç; özge eda karadağ aytemiz
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal